Skip to main content
. 2016 May 4;9(3):411–417. doi: 10.1093/ckj/sfw024

Fig. 3.

Fig. 3.

Clinical course of the patient. Serum creatinine, timing of nivolumab and ipilimumab administration, kidney biopsy procedure and treatment course are shown. Time course was described as weeks after the first dose of nivolumab/ipilimumab.